Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Tang Capital Management Kevin C. Tang | 2,254,797 | $124,848,110 | 8.26% | |
2. | Millennium Management Israel Englander | 644,010 | $35,658,834 | +190% | 0.01% |
3. | Ikarian Capital Neil Shahrestani | 607,689 | $33,647,740 | -42% | 4.57% |
4. | Cormorant Asset Management Bihua Chen | 500,000 | $27,685,000 | 1.52% | |
5. | Leucadia National Ian Cumming And Joseph Steinberg | 420,758 | $23,297,370 | 0.14% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$18.96 | 1,000 | Director | 3,000 | 2023-12-15 | Filing | |
$16.80 | 9,506 | Director | 15,866 | 2023-08-15 | Filing | |
$16.29 | 6,360 | Director | 6,360 | 2022-09-14 | Filing | |
$16.03 | 12,040 | Director | 12,040 | 2022-09-14 | Filing | |
$13.50 | 100,000 | Director | 100,000 | 2022-05-05 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$50.00 | 6,000 | Officer, Director | 824,106 | 2025-03-24 | Filing | |
$50.11 | 3,365 | Officer | 65,057 | 2025-03-20 | Filing | |
$47.40 | 3,557 | Officer | 68,422 | 2025-03-19 | Filing | |
$46.29 | 3,643 | Officer | 71,979 | 2025-03-18 | Filing | |
$50.11 | 2,435 | Officer | 79,682 | 2025-03-20 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 3,538,845 | $195,945,847 | 0% | |
2. | 3,236,549 | $179,207,718 | 2.71% | |
3. | 2,531,896 | $140,191,082 | 4.87% | |
4. | 2,500,132 | $138,432,310 | 0.08% | |
5. | 2,115,162 | $117,116,520 | 0% |